
Beyond Animals Models
Toward True Human Relevance
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Explore Our Products
Explore Our Services
Human-Relevant Platforms
for Predictive Discovery
At Ananda Devices, we develop human-relevant organ-on-a-chip systems that replicate neuromuscular and neuronal physiology, enabling predictive preclinical data generation aligned with New Approach Methods (NAMs) and the FDA Modernization Act.
Browse Our Case Studies

Trusted by
Worldwide
Numerous Pharma, Biotech & Governmental Institutions
Why Researchers
Trust
At Ananda Devices, we’re redefining preclinical testing to reflect real human biology. With more than 99% of neurological drugs failing in clinical trials, the industry needs a better way.
Human-Relevant, Translational Platforms
Translational human cell–based NeuroMuscle™ and NeuroHTS™ systems generate human-relevant, translationally informative data—bridging discovery and patient outcomes.
Aligned with Regulators & Industry Leaders
Collaborating with leading pharmaceutical organizations and the U.S. FDA to advance regulatory-aligned, human-relevant testing strategies.
Scalable & Ethically Compliant
Ready-to-run, scalable human biology platforms that reduce reliance on animal models while supporting global 3Rs initiatives.
Multiparametric, Real-Time Insights
Continuously monitor neuronal and neuromuscular networks—capturing structure, function, connectivity, and treatment response over time, including including countermeasure development of drug or toxin effects.
Ananda's Technology
NeuroHTS™
High-Throughput Human Neuronal Networks
NeuroHTS provides precisely organized networks for improved neuronal connectively, morphology and function - all in one assay. Advantages include precisely organized neuronal networks for reproducible screening, multiparametric high-throughput workflows, compatibility with primary & iPSC-derived neurons, and ideal applicability for neurotoxicity, regeneration & CNS drug discovery.

Ananda's Technology
NeuroMuscle™
High-Throughput Human Neuronal Networks
NeuroMuscle(TM) provides a 3D model of a human neuromuscular junction that allows motor neurons to innervate skeletal muscle and generate multiparameter quantitative measure of muscle contraction - both amplitude and frequency. The system can be used for toxicity assessment, countermeasure development and analysis of disease states for ALS, SMA, MG and many others.

Built with
Our Partners
25
Total Awards
1B+
Neurons analyzed
20+
Years Experience
We collaborate with pharmaceutical, biotechnology, Government and academic innovators to accelerate translational research and generate predictive human data that strengthens early development decisions.
We provide the tools for partners advance studies with greater reproducibility, scalability, and translational relevance.
Explore More Collaborations
Collaboration with UCB Pharma
Patient-derived neuromuscular models supporting Myasthenia Gravis drug-development decisions.
See Details

Partnership with the U.S. FDA
Supporting qualification of our platform as a NAM drug development tool and toxin testing.
See Details

Redefining
Preclinical Testing
with Human Biology
Founded in 2015, Ananda Devices builds human-relevant organ-on-a-chip platforms that enable predictive, scalable, and ethical preclinical testing beyond animal models.
Explore More Collaborations
Building Reproducibility into Preclinical Science
Our Recents

15:00
Reproducibility
Standardization
Canada Advances National Strategy for NAM Adoption
Jun 25, 2025
By Allan Ren
The challenge in neuroscience is the lack of access to human neural tissue, and the historical reliance on animal models. Biological standardization with human data is critically needed.
Read More

Bring human-relevant insights to your drug pipeline today!
Learn how Ananda’s solutions support decisions across drug discovery, toxicology, and translational research.
Explore Technologies
Request a Proposal

Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
Terms and Conditions
Languages: EN




Beyond Animals Models
Toward True Human Relevance
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Explore Our Products
Explore Our Services
Human-Relevant Platforms
for Predictive Discovery
At Ananda Devices, we develop human-relevant organ-on-a-chip systems that replicate neuromuscular and neuronal physiology, enabling predictive preclinical data generation aligned with New Approach Methods (NAMs) and the FDA Modernization Act.
Browse Our Case Studies

Trusted by
Worldwide
Numerous Pharma, Biotech & Governmental Institutions
Why Researchers
Trust
At Ananda Devices, we’re redefining preclinical testing to reflect real human biology. With more than 99% of neurological drugs failing in clinical trials, the industry needs a better way.
Human-Relevant, Translational Platforms
Translational human cell–based NeuroMuscle™ and NeuroHTS™ systems generate human-relevant, translationally informative data—bridging discovery and patient outcomes.
Aligned with Regulators & Industry Leaders
Collaborating with leading pharmaceutical organizations and the U.S. FDA to advance regulatory-aligned, human-relevant testing strategies.
Scalable & Ethically Compliant
Ready-to-run, scalable human biology platforms that reduce reliance on animal models while supporting global 3Rs initiatives.
Multiparametric, Real-Time Insights
Continuously monitor neuronal and neuromuscular networks—capturing structure, function, connectivity, and treatment response over time, including including countermeasure development of drug or toxin effects.
Ananda's Technology
NeuroHTS™
High-Throughput Human Neuronal Networks
NeuroHTS provides precisely organized networks for improved neuronal connectively, morphology and function - all in one assay. Advantages include precisely organized neuronal networks for reproducible screening, multiparametric high-throughput workflows, compatibility with primary & iPSC-derived neurons, and ideal applicability for neurotoxicity, regeneration & CNS drug discovery.

Built with
Our Partners
25
Total Awards
1B+
Neurons analyzed
20+
Years Experience
We collaborate with pharmaceutical, biotechnology, Government and academic innovators to accelerate translational research and generate predictive human data that strengthens early development decisions.
We provide the tools for partners advance studies with greater reproducibility, scalability, and translational relevance.
Explore More Collaborations
Collaboration with UCB Pharma
Patient-derived neuromuscular models supporting Myasthenia Gravis drug-development decisions.
See Details

Partnership with the U.S. FDA
Supporting qualification of our platform as a NAM drug development tool and toxin testing.
See Details


Redefining
Preclinical Testing
with Human Biology
Founded in 2015, Ananda Devices builds human-relevant organ-on-a-chip platforms that enable predictive, scalable, and ethical preclinical testing beyond animal models.
Explore More Collaborations
Building Reproducibility into Preclinical Science
Our Recents

15:00
Reproducibility
Standardization
Canada Advances National Strategy for NAM Adoption
Jun 25, 2025
By Allan Ren
The challenge in neuroscience is the lack of access to human neural tissue, and the historical reliance on animal models. Biological standardization with human data is critically needed.
Read More

Bring human-relevant insights to your drug pipeline today!
Learn how Ananda’s solutions support decisions across drug discovery, toxicology, and translational research.
Explore Technologies
Request a Proposal

Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
|
Terms and Conditions
|
Languages: EN


Home
About Us
Our Platforms
Our Services
Our Resources
Contact Us
Client Portal
EN


Beyond Animals Models
Toward True Human Relevance
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Explore Our Products
Explore Our Services
Human-Relevant Platforms
for Predictive Discovery
At Ananda Devices, we develop human-relevant organ-on-a-chip systems that replicate neuromuscular and neuronal physiology, enabling predictive preclinical data generation aligned with New Approach Methods (NAMs) and the FDA Modernization Act.
Browse Our Case Studies

Trusted by
Worldwide
Numerous Pharma, Biotech & Governmental Institutions
Why Researchers
Trust
At Ananda Devices, we’re redefining preclinical testing to reflect real human biology. With more than 99% of neurological drugs failing in clinical trials, the industry needs a better way.
Human-Relevant, Translational Platforms
Translational human cell–based NeuroMuscle™ and NeuroHTS™ systems generate human-relevant, translationally informative data—bridging discovery and patient outcomes.
Aligned with Regulators & Industry Leaders
Collaborating with leading pharmaceutical organizations and the U.S. FDA to advance regulatory-aligned, human-relevant testing strategies.
Scalable & Ethically Compliant
Ready-to-run, scalable human biology platforms that reduce reliance on animal models while supporting global 3Rs initiatives.
Multiparametric, Real-Time Insights
Continuously monitor neuronal and neuromuscular networks—capturing structure, function, connectivity, and treatment response over time, including including countermeasure development of drug or toxin effects.
Ananda's Technology
NeuroHTS™
High-Throughput Human Neuronal Networks
NeuroHTS provides precisely organized networks for improved neuronal connectively, morphology and function - all in one assay. Advantages include precisely organized neuronal networks for reproducible screening, multiparametric high-throughput workflows, compatibility with primary & iPSC-derived neurons, and ideal applicability for neurotoxicity, regeneration & CNS drug discovery.

Built with
Our Partners
25
Total Awards
1B+
Neurons analyzed
20+
Years Experience
We collaborate with pharmaceutical, biotechnology, Government and academic innovators to accelerate translational research and generate predictive human data that strengthens early development decisions.
We provide the tools for partners advance studies with greater reproducibility, scalability, and translational relevance.
Explore More Collaborations
Collaboration with UCB Pharma
Patient-derived neuromuscular models supporting Myasthenia Gravis drug-development decisions.
See Details

Partnership with the U.S. FDA
Supporting qualification of our platform as a NAM drug development tool and toxin testing.
See Details


Redefining
Preclinical Testing
with Human Biology
Founded in 2015, Ananda Devices builds human-relevant organ-on-a-chip platforms that enable predictive, scalable, and ethical preclinical testing beyond animal models.
Explore More Collaborations
Building Reproducibility into Preclinical Science
Our Recents
View More Insights


15:00
Reproducibility
Standardization
Canada Advances National Strategy for NAM Adoption
Jun 25, 2025
By Allan Ren
The challenge in neuroscience is the lack of access to human neural tissue, and the historical reliance on animal models. Biological standardization with human data is critically needed.
Read More

Bring human-relevant insights to your drug pipeline today!
Learn how Ananda’s solutions support decisions across drug discovery, toxicology, and translational research.
Explore Technologies
Request a Proposal

Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
|
Terms and Conditions
|
Languages: EN


Home
About Us
Our Platforms
Our Services
Our Resources
Contact Us
Client Portal
EN